HEALTHY DIETS AND SCIENCE: Statins associated with 30% increased risk of death in kidney transplant patients

The raison d'etre of this website is to provide you with hard scientific information which may help you make informed decisions in your quest for health (so far I have blogged concise summaries of over 1,500 scientific studies and have had three books published).

My research is mainly focused on the effects of cholesterol, saturated fat and statin drugs on health. If you know anyone who is worried about their cholesterol levels and heart disease, or has been told to take statin drugs you could send them a link to this website, and to my statin or cholesterol or heart disease books.

David Evans

Independent Health Researcher

Sunday 24 January 2016

Statins associated with 30% increased risk of death in kidney transplant patients

2009 Apr 15;(2):CD005019

Study title and authors:

HMG CoA reductase inhibitors (statins) for kidney transplant recipients.

Navaneethan SD, Perkovic V, Johnson DW, Nigwekar SU, Craig JC, Strippoli GF.

Department of Nephrology and Hypertension, Glickman Urological and Kidney institute, Cleveland Clinic, Cleveland, OH 44195, USA. navanes@ccf.org

This paper can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/19370615

This paper assessed the effects of statin therapy on kidney transplant recipients. The paper analysed the results of 14 studies with 3,045 participants that compared death rates of patients.

The analysis found that kidney transplant patients that received statins had a 30% increased risk of death compared to patients who did not take statins.